These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28729853)

  • 21. Inhibition of pancreatic exocrine secretion in the rat by calcitonin gene-related peptide: involvement of circulating somatostatin.
    Mulholland MW; Garcia R; Garcia I; Taborsky GJ; Helton S
    Endocrinology; 1989 Apr; 124(4):1849-56. PubMed ID: 2466638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A little-known new components of the appetite control].
    Nylec M; Olszanecka-Glinianowicz M
    Postepy Hig Med Dosw (Online); 2010 Jun; 64():291-5. PubMed ID: 20558867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic regulation of glucose homeostasis.
    Röder PV; Wu B; Liu Y; Han W
    Exp Mol Med; 2016 Mar; 48(3):e219. PubMed ID: 26964835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The control of adenohypophysial hormone secretion by amino acids and peptides in swine.
    Estienne MJ; Barb CR
    Domest Anim Endocrinol; 2005 Jul; 29(1):34-42. PubMed ID: 15927765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells.
    D'Amour KA; Bang AG; Eliazer S; Kelly OG; Agulnick AD; Smart NG; Moorman MA; Kroon E; Carpenter MK; Baetge EE
    Nat Biotechnol; 2006 Nov; 24(11):1392-401. PubMed ID: 17053790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastroenteropancreatic hormones and metabolism in fish.
    Nelson LE; Sheridan MA
    Gen Comp Endocrinol; 2006 Sep; 148(2):116-24. PubMed ID: 16516213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in the regulation of pancreatic secretion.
    Chandra R; Liddle RA
    Curr Opin Gastroenterol; 2014 Sep; 30(5):490-4. PubMed ID: 25003603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mast Cell and M1 Macrophage Infiltration and Local Pro-Inflammatory Factors Were Attenuated with Incretin-Based Therapies in Obesity-Related Glomerulopathy.
    He J; Yuan G; Cheng F; Zhang J; Guo X
    Metab Syndr Relat Disord; 2017 Sep; 15(7):344-353. PubMed ID: 28737448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of incretin-based therapies on neurocognitive function in humans: A systematic review of the literature.
    Dumbrill JL; Moulton CD
    Prim Care Diabetes; 2018 Feb; 12(1):51-58. PubMed ID: 28732654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In Vitro comparison of 213Bi- and 177Lu-radiation for peptide receptor radionuclide therapy.
    Chan HS; de Blois E; Morgenstern A; Bruchertseifer F; de Jong M; Breeman W; Konijnenberg M
    PLoS One; 2017; 12(7):e0181473. PubMed ID: 28732021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment.
    Richards JR; Lapoint JM; Burillo-Putze G
    Clin Toxicol (Phila); 2018 Jan; 56(1):15-24. PubMed ID: 28730896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The galanin and galanin receptor subtypes, its regulatory role in the biological and pathological functions.
    Šípková J; Kramáriková I; Hynie S; Klenerová V
    Physiol Res; 2017 Nov; 66(5):729-740. PubMed ID: 28730831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of semaglutide once weekly vs sitagliptin once daily, both as monotherapy in Japanese people with type 2 diabetes.
    Seino Y; Terauchi Y; Osonoi T; Yabe D; Abe N; Nishida T; Zacho J; Kaneko S
    Diabetes Obes Metab; 2018 Feb; 20(2):378-388. PubMed ID: 28786547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Sustained Effects of a Dual GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes.
    Frias JP; Bastyr EJ; Vignati L; Tschöp MH; Schmitt C; Owen K; Christensen RH; DiMarchi RD
    Cell Metab; 2017 Aug; 26(2):343-352.e2. PubMed ID: 28768173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GLP-1/glucagon receptor co-agonism for treatment of obesity.
    Sánchez-Garrido MA; Brandt SJ; Clemmensen C; Müller TD; DiMarchi RD; Tschöp MH
    Diabetologia; 2017 Oct; 60(10):1851-1861. PubMed ID: 28733905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin receptor signaling and glucagon-like peptide 1 effects on pancreatic beta cells.
    Caporarello N; Parrino C; Trischitta V; Frittitta L
    PLoS One; 2017; 12(8):e0181190. PubMed ID: 28767692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beneficial long-term antidiabetic actions of N- and C-terminally modified analogues of apelin-13 in diet-induced obese diabetic mice.
    Parthsarathy V; Hogg C; Flatt PR; O'Harte FPM
    Diabetes Obes Metab; 2018 Feb; 20(2):319-327. PubMed ID: 28730728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatostatin analogues labeled with copper radioisotopes: current status.
    Marciniak A; Brasuń J
    J Radioanal Nucl Chem; 2017; 313(2):279-289. PubMed ID: 28804185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of AP102, a subtype 2 and 5 specific somatostatin analog, on glucose metabolism in rats.
    Tarasco E; Seebeck P; Pfundstein S; Daly AF; Eugster PJ; Harris AG; Grouzmann E; Lutz TA; Boyle CN
    Endocrine; 2017 Oct; 58(1):124-133. PubMed ID: 28822091
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Oshima N; Akizawa H; Kitaura H; Kawashima H; Zhao S; Zhao Y; Nishijima KI; Kitamura Y; Arano Y; Kuge Y; Ohkura K
    Nucl Med Biol; 2017 Nov; 54():18-26. PubMed ID: 28821003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.